Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

PROGESTERONE

Unique Identifier:SPE01500508
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:
Molecular Weight:284.224 g/mol
X log p:1.893  (online calculus)
Lipinksi Failures0
TPSA34.14
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:2
Rotatable Bond Count:1
Canonical Smiles:CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C
Source:semisynthetic
Therapeutics:progestogen
Generic_name:Progesterone
Chemical_iupac_name:17-acetyl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopent
a[a]phenanthren-3-one
Drug_type:Approved Drug
Pharmgkb_id:PA451123
Kegg_compound_id:C00410
Drugbank_id:APRD00700
Melting_point:121 oC
H2o_solubility:8.81 mg/L
Logp:4.036
Cas_registry_number:57-83-0
Mass_spectrum:http://webbook.nist.gov/cgi/cbook.cgi?Spec=C57830&Index=0&Type=Mass&Large=on
Drug_category:Contraceptives; Progestins; ATC:G03AC06; ATC:G03DA02; ATC:G03DA03; ATC:G03DA04;
ATC:L02AB02
Indication:For progesterone supplementation or replacement as part of an Assisted Reproductive
Technology (ART) treatment for infertile women with progesterone deficiency and for
the treatment of secondary amenorrhea. Also used as a female contraceptive.
Pharmacology:Progesterone is a progestin or a synthetic form of the naturally occurring female
sex hormone, progesterone. In a woman-s normal menstrual cycle, an egg matures and
is released from the ovaries (ovulation). The ovary then produces progesterone,
preventing the release of further eggs and priming the lining of the womb for a
possible pregnancy. If pregnancy occurs, progesterone levels in the body remain
high, maintaining the womb lining. If pregnancy does not occur, progesterone levels
in the body fall, resulting in a menstrual period. Progesterone tricks the body
processes into thinking that ovulation has already occurred, by maintaining high
levels of the synthetic progesterone. This prevents the release of eggs from the
ovaries.
Mechanism_of_action:Binds to the progesterone and estrogen receptors. Target cells include the female
reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once
bound to the receptor, progestins like Progesterone will slow the frequency of
release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the
pre-ovulatory LH (luteinizing hormone) surge.
Organisms_affected:Humans and other mammals

Found: 62 active | as graph: single | with analogs [1] << Back 41 42 43 44 45 46 47 48 49 50  Next >> [62]
Species: 4932
Condition: BCK1
Replicates: 2
Raw OD Value: r im 0.6133±0.0159099
Normalized OD Score: sc h 0.8234±0.00246839
Z-Score: -4.3523±0.125202
p-Value: 0.0000145321
Z-Factor: 0.597861
Fitness Defect: 11.1392
Bioactivity Statement: Active
Experimental Conditions
Library:SPECMTS3
Plate Number and Position:19|C11
Drug Concentration:50.00 nM
OD Absorbance:600 nm
Robot Temperature:24.60 Celcius
Date:2008-05-14 YYYY-MM-DD
Plate CH Control (+):0.040175±0.00122
Plate DMSO Control (-):0.6908499999999999±0.00869
Plate Z-Factor:0.9573
png
ps
pdf

DBLink | Rows returned: 406[1] << Back 21 22 23 24 25 26 27 28 29 30  Next >> [68]
556211 1-methylbicyclo[5.4.0]undec-7-en-9-one
556245 10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-17-carbaldehyde
556741 1-methylbicyclo[4.2.0]oct-3-en-5-one
557670 3,6-dimethyl-6-propan-2-yl-cyclohex-2-en-1-one
565274 4a,8a-dimethyl-5,6,7,8-tetrahydro-1H-naphthalen-2-one
565275 2-(4a,8-dimethyl-6-oxo-1,2,3,4,5,8a-hexahydronaphthalen-2-yl)propanal

internal high similarity DBLink | Rows returned: 122 Next >> 
RJC 03876 0.9048
NRB 03820 0.9268
SPE01505219 0.9744
NRB 03818 1.0000
LOPAC 01120 1.0000
NRB 03821 1.0000

active | Cluster 2094 | Additional Members: 20 | Rows returned: 6
SPE00300034 0.375
SPE00307023 0.348484848484849
SPE00300029 0.285714285714286
LAT002C06 0
LAT005F10 0
LOPAC 01120 0

Service provided by the Mike Tyers Laboratory